Lv1
60 积分 2022-03-21 加入
Sparsentan in patients with IgA nephropathy: a prespecified interim analysis from a randomised, double-blind, active-controlled clinical trial
3小时前
待确认
Long-term outcomes of IgA nephropathy in China
9小时前
已完结
Efficacy and safety of sparsentan versus irbesartan in patients with IgA nephropathy (PROTECT): 2-year results from a randomised, active-controlled, phase 3 trial
1天前
已完结
Pitavastatin Combined with Ezetimibe Treatment was an Effective Approach to Non-IRA Lesion of ST-segment Elevation Myocardial Infarction Patients with Primary Percutaneous Coronary Intervention
3天前
已完结
PCSK9 inhibitor added to high-intensity statin therapy to prevent cardiovascular events in patients with acute coronary syndrome after percutaneous coronary intervention: a randomized, double- blind, placebo-controlled, multicenter SHAWN study
3天前
已完结
Administration of Evolocumab in Patients with STEMI After Emergency PCI: A Real-World Cohort Study
4天前
已完结
Evaluating the Real-World Safety of Icosapent Ethyl Versus Omega-3 Polyunsaturated Fatty Acid in Nationwide US Veterans Cohort: Examining Atrial Fibrillation and Bleeding Endpoints
5天前
已完结
GRADE guidelines: 1. Introduction—GRADE evidence profiles and summary of findings tables
9天前
已完结
Accuracy of Information given by ChatGPT for Patients with Inflammatory Bowel Disease in Relation to ECCO Guidelines
10天前
已完结
Credibility of ChatGPT in the assessment of obesity in type 2 diabetes according to the guidelines
10天前
已完结
皖公网安备34019202002308
